# OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension

> **NCT01642212** · PHASE2 · COMPLETED · sponsor: **Shire** · enrollment: 93 (actual)

## Conditions studied

- Eosinophilic Esophagitis (EoE)

## Interventions

- **DRUG:** Oral Budesonide Suspension (MB-9)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01642212
- **Lead sponsor:** Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07-23
- **Primary completion:** 2014-10-30
- **Final completion:** 2014-10-30
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2021-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01642212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01642212, "OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01642212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*